Protalix BioTherapeutics ... (PLX)
AMEX: PLX
· Real-Time Price · USD
1.48
-0.04 (-2.63%)
At close: Aug 15, 2025, 3:59 PM
1.50
1.35%
After-hours: Aug 15, 2025, 05:59 PM EDT
Protalix BioTherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 59.76M | 53.4M | 45.67M | 38.05M | 59.65M | 65.49M | 63.63M | 67.46M | 41.14M | 47.64M | 47.57M | 45.44M | 43.12M | 38.35M | 49.3M | 48.03M | 52.57M |
Cost of Revenue | 29.9M | 24.32M | 29.29M | 25.81M | 22.5M | 22.98M | 16.52M | 18.7M | 16.64M | 19.59M | 20.34M | 16.97M | 17.62M | 16.35M | 15.95M | 15.12M | 12.21M |
Gross Profit | 29.87M | 29.08M | 16.38M | 12.25M | 37.16M | 42.51M | 47.1M | 48.76M | 24.5M | 28.05M | 27.23M | 28.47M | 25.5M | 22M | 33.34M | 32.91M | 40.36M |
Operating Income | 4.63M | 3.92M | -8.91M | -14.79M | 8.06M | 10.46M | 13.58M | 12.34M | -13.6M | -13.01M | -16.23M | -14.98M | -18.63M | -20.46M | -11.92M | -12.61M | -5.69M |
Interest Income | 1.21M | 1.3M | 1.15M | 1.63M | 1.64M | 1.29M | 1.33M | 900K | 1.18M | 1.21M | 1.21M | 1.11M | 426K | 559K | 638K | 660K | 570K |
Pretax Income | 5.16M | 4.15M | -9.59M | -15.15M | 6.77M | 8.57M | 11.78M | 9.93M | -15.05M | -14.4M | -17.85M | -18.49M | -24.39M | -27.58M | -20.52M | -20.76M | -13.66M |
Net Income | 3.91M | 2.93M | -9.61M | -14.69M | 6.85M | 8.31M | 10.62M | 8.9M | -15.77M | -14.93M | -17.85M | -18.49M | -24.39M | -27.58M | -20.52M | -20.76M | -13.66M |
Selling & General & Admin | 11.68M | 12.19M | 13.34M | 14.41M | 14.96M | 14.96M | 13.91M | 13.09M | 11.67M | 11.71M | 12.08M | 12.19M | 12.74M | 12.73M | 12.21M | 12.08M | 11.1M |
Research & Development | 13.56M | 12.97M | 11.95M | 12.62M | 14.13M | 17.09M | 19.61M | 23.32M | 26.43M | 29.35M | 31.37M | 31.27M | 31.38M | 29.73M | 33.05M | 33.45M | 34.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51K | 51K | 51K | 51K |
Operating Expenses | 25.24M | 25.16M | 25.29M | 27.03M | 29.09M | 32.05M | 33.52M | 36.42M | 38.1M | 41.06M | 43.45M | 43.45M | 44.12M | 42.46M | 45.26M | 45.53M | 46.05M |
Interest Expense | 678K | 1.06M | 1.83M | 1.99M | 2.93M | 3.19M | 3.13M | 3.31M | 2.63M | 2.6M | 3.62M | 5.39M | 6.97M | 8.51M | 9.29M | 8.85M | 8.6M |
Selling & Marketing Expenses | n/a | n/a | 10.11M | 20.28M | 35.35M | 40.42M | 55.6M | 54.24M | 42.55M | 46.51M | 21.22M | 16.92M | 16.78M | 12.26M | 12.26M | 11.05M | 11.46M |
Cost & Expenses | 55.14M | 49.48M | 54.57M | 52.84M | 51.59M | 55.03M | 50.05M | 55.12M | 54.74M | 60.65M | 63.8M | 60.43M | 61.74M | 58.81M | 61.21M | 60.65M | 58.26M |
Income Tax Expense | 1.25M | 1.22M | 18K | -456K | -79K | 254K | 1.17M | 1.03M | 725K | 530K | n/a | n/a | n/a | n/a | n/a | n/a | 38K |
Shares Outstanding (Basic) | 76.61M | 73.55M | 73.55M | 73.31M | 73.04M | 72.95M | 72.28M | 67.16M | 57.48M | 51.34M | 49.5M | 47.33M | 45.72M | 45.28M | 45.56M | 45.44M | 39.93M |
Shares Outstanding (Diluted) | 76.61M | 81.06M | 81.22M | 73.31M | 73.04M | 72.95M | 83.78M | 83.2M | 57.48M | 51.34M | 49.5M | 47.33M | 45.84M | 45.56M | 45.56M | 45.44M | 39.93M |
EPS (Basic) | n/a | -0.01 | -0.13 | -0.2 | 0.12 | 0.13 | 0.14 | 0.10 | -0.3 | -0.3 | -0.38 | -0.4 | -0.54 | -0.63 | -0.47 | -0.52 | -0.4 |
EPS (Diluted) | -0.01 | -0.02 | -0.14 | -0.19 | 0.05 | 0.06 | 0.07 | 0.02 | -0.3 | -0.3 | -0.38 | -0.4 | -0.54 | -0.63 | -0.47 | -0.52 | -0.4 |
EBITDA | 7.16M | 6.52M | -6.47M | -11.9M | 10.93M | 12.95M | 16M | 14.3M | -11.39M | -10.78M | -14M | -12.85M | -17.15M | -18.79M | -10.16M | -10.82M | -3.93M |
EBIT | 5.83M | 5.22M | -7.76M | -13.16M | 9.7M | 11.75M | 14.85M | 13.18M | -12.49M | -11.87M | -15.07M | -13.93M | -18.25M | -19.91M | -11.23M | -11.9M | -5.07M |
Depreciation & Amortization | 1.33M | 1.3M | 1.28M | 1.26M | 1.23M | 1.19M | 1.15M | 1.12M | 1.1M | 1.09M | 1.07M | 1.08M | 1.1M | 1.12M | 1.15M | 1.17M | 1.21M |